NYSE:ALB - Albemarle Stock Price, News, & Analysis

Albemarle trades on the New York Stock Exchange (NYSE) under the ticker symbol "ALB."

Albemarle declared a quarterly dividend on Tuesday, February 26th. Stockholders of record on Friday, March 15th will be given a dividend of $0.3675 per share on Monday, April 1st. This represents a $1.47 annualized dividend and a dividend yield of 1.78%. The ex-dividend date of this dividend is Thursday, March 14th. This is an increase from Albemarle's previous quarterly dividend of $0.34. View Albemarle's Dividend History.

Albemarle Co. (NYSE:ALB) posted its quarterly earnings data on Wednesday, February, 20th. The specialty chemicals company reported $1.53 EPS for the quarter, topping the Zacks' consensus estimate of $1.46 by $0.07. The specialty chemicals company earned $921.70 million during the quarter, compared to analysts' expectations of $894.45 million. Albemarle had a return on equity of 15.82% and a net margin of 20.55%. The company's revenue for the quarter was up 7.4% compared to the same quarter last year. During the same period last year, the business posted $1.34 EPS. View Albemarle's Earnings History.

Albemarle is scheduled to release their next quarterly earnings announcement on Wednesday, May 8th 2019. View Earnings Estimates for Albemarle.

Albemarle updated its FY19 earnings guidance on Wednesday, February, 20th. The company provided EPS guidance of $6.10-6.50 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $6.14. The company issued revenue guidance of $3.65-3.85 billion, compared to the consensus revenue estimate of $3.64 billion.Albemarle also updated its FY 2019 guidance to $6.10-6.50 EPS.

15 brokers have issued 12 month price objectives for Albemarle's stock. Their predictions range from $59.00 to $125.00. On average, they anticipate Albemarle's share price to reach $102.2407 in the next twelve months. This suggests a possible upside of 23.6% from the stock's current price. View Analyst Price Targets for Albemarle.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Albemarle in the last year. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Albemarle.

News stories about ALB stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Albemarle earned a media sentiment score of 0.5 on InfoTrie's scale. They also assigned press coverage about the specialty chemicals company a news buzz of 2.0 out of 10, indicating that recent media coverage is very unlikely to have an impact on the company's share price in the next few days.

Some companies that are related to Albemarle include Eastman Chemical (EMN), Hexcel (HXL), Sinopec Shanghai Petrochemical (SHI), Rogers (ROG), PolyOne (POL), Trinseo (TSE), Kraton (KRA), AdvanSix (ASIX), Cereplast (CERPQ), A Schulman (SHLM) and ForceField Energy (FNRG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Albemarle investors own include Intact Financial (IFC), Constellation Software (CSU), NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), AbbVie (ABBV), Intel (INTC), Netflix (NFLX), Tesla (TSLA) and General Electric (GE).

Albemarle's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.01%), Jennison Associates LLC (6.55%), Bank of New York Mellon Corp (3.02%), Baillie Gifford & Co. (2.48%), Bank of America Corp DE (1.78%) and Iridian Asset Management LLC CT (1.63%). Company insiders that own Albemarle stock include Douglas L Maine, Karen G Narwold, Luther C Iv Kissam, Matthew Juneau and Scott Tozier. View Institutional Ownership Trends for Albemarle.

ALB stock was sold by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Jennison Associates LLC, Carmignac Gestion, Mirae Asset Global Investments Co. Ltd., Iridian Asset Management LLC CT, QCI Asset Management Inc. NY, Anchor Bolt Capital LP and United Services Automobile Association. Company insiders that have sold Albemarle company stock in the last year include Karen G Narwold and Scott Tozier. View Insider Buying and Selling for Albemarle.

ALB stock was purchased by a variety of institutional investors in the last quarter, including Norges Bank, Eagle Asset Management Inc., State of Tennessee Treasury Department, Principal Financial Group Inc., Robecosam AG, CIBC Private Wealth Group LLC, Dimensional Fund Advisors LP and Handelsbanken Fonder AB. View Insider Buying and Selling for Albemarle.

Shares of ALB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of ALB stock can currently be purchased for approximately $82.72.

Albemarle has a market capitalization of $8.75 billion and generates $3.37 billion in revenue each year. The specialty chemicals company earns $693.56 million in net income (profit) each year or $5.48 on an earnings per share basis. Albemarle employs 5,900 workers across the globe.

The official website for Albemarle is http://www.albemarle.com.

Albemarle's mailing address is 4250 CONGRESS STREET SUITE 900, CHARLOTTE NC, 28209. The specialty chemicals company can be reached via phone at 980-299-5700 or via email at [email protected]